Stryker Corp (SYK)
367.15
+10.87
(+3.05%)
USD |
NYSE |
Nov 01, 16:00
366.86
-0.29
(-0.08%)
After-Hours: 20:00
Stryker Enterprise Value: 150.76B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 150.76B |
| October 31, 2024 | 146.62B |
| October 30, 2024 | 149.35B |
| October 29, 2024 | 147.66B |
| October 28, 2024 | 146.52B |
| October 25, 2024 | 145.30B |
| October 24, 2024 | 148.00B |
| October 23, 2024 | 149.27B |
| October 22, 2024 | 150.33B |
| October 21, 2024 | 150.80B |
| October 18, 2024 | 151.68B |
| October 17, 2024 | 147.93B |
| October 16, 2024 | 148.54B |
| October 15, 2024 | 147.65B |
| October 14, 2024 | 147.93B |
| October 11, 2024 | 146.36B |
| October 10, 2024 | 145.51B |
| October 09, 2024 | 145.74B |
| October 08, 2024 | 144.53B |
| October 07, 2024 | 142.37B |
| October 04, 2024 | 144.69B |
| October 03, 2024 | 144.84B |
| October 02, 2024 | 146.17B |
| October 01, 2024 | 147.00B |
| September 30, 2024 | 148.52B |
| Date | Value |
|---|---|
| September 27, 2024 | 147.56B |
| September 26, 2024 | 147.97B |
| September 25, 2024 | 147.26B |
| September 24, 2024 | 147.83B |
| September 23, 2024 | 149.94B |
| September 20, 2024 | 149.29B |
| September 19, 2024 | 149.38B |
| September 18, 2024 | 147.97B |
| September 17, 2024 | 148.96B |
| September 16, 2024 | 152.01B |
| September 13, 2024 | 151.36B |
| September 12, 2024 | 150.42B |
| September 11, 2024 | 149.87B |
| September 10, 2024 | 149.38B |
| September 09, 2024 | 148.51B |
| September 06, 2024 | 147.04B |
| September 05, 2024 | 146.69B |
| September 04, 2024 | 147.57B |
| September 03, 2024 | 147.31B |
| August 30, 2024 | 147.61B |
| August 29, 2024 | 146.66B |
| August 28, 2024 | 145.99B |
| August 27, 2024 | 146.88B |
| August 26, 2024 | 145.28B |
| August 23, 2024 | 144.90B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
54.08B
Minimum
Mar 23 2020
152.01B
Maximum
Sep 16 2024
107.46B
Average
107.47B
Median
Feb 16 2022
Enterprise Value Benchmarks
| Globus Medical Inc | 10.08B |
| Boston Scientific Corp | 131.03B |
| Alphatec Holdings Inc | 1.596B |
| Orthofix Medical Inc | 739.08M |
| Treace Medical Concepts Inc | 255.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 834.00M |
| Revenue (Quarterly) | 5.494B |
| Total Expenses (Quarterly) | 4.409B |
| EPS Diluted (Quarterly) | 2.16 |
| Gross Profit Margin (Quarterly) | 64.02% |
| Profit Margin (Quarterly) | 15.18% |
| Earnings Yield | 2.54% |
| Operating Earnings Yield | 3.10% |
| Normalized Earnings Yield | 2.541 |